This document provides guidance and advice on user safety risk assessments. It applies to new applications and renewals of marketing authorisation for immunological veterinary medicinal products and does not require the generation of specific or additional data.

Keywords: User safety, hazard identification and characterisation, exposure assessment risk characterisation, risk management, risk communication

Current effective version

Document history

Share this page